Potential microRNA panel for the diagnosis and prediction of overall survival of hepatocellular carcinoma with hepatitis B virus infection

被引:0
|
作者
Qi Zhang [1 ]
Hai-Feng Xu [2 ]
Wen-Yue Song [1 ]
Peng-Jun Zhang [2 ]
Yong-Bo Song [1 ]
机构
[1] School of Life Science and Biopharmaceutics,Shenyang Pharmaceutical University
[2] Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Interventional Therapy Department, Peking University Cancer Hospital and Institute
基金
国家重点研发计划;
关键词
Hepatitis B virus infection; Hepatocellular carcinoma; MicroRNAs; Cirrhosis; Biomarker; Tissue;
D O I
暂无
中图分类号
R735.7 [肝肿瘤]; R512.62 [];
学科分类号
100214 ; 100401 ;
摘要
BACKGROUND In hepatocellular carcinoma(HCC), abnormal expression of multiple micro RNAs(miRNAs) has been shown to be involved in the malignant biological behavior of liver cancer. The vast majority of liver cancer cases in China are closely related to hepatitis B virus(HBV) infection, but there are few studies on the changes of miRNA expression in the progression from HBV infection to hepatoma.AIM To explore the role of miRNAs in the progression of HBV infection to cirrhosis and even to liver cancer.METHODS We screened differentially expressed miRNAs in 40 HBV cirrhosis, 40 normal and15 HCC tissues by using a Taq Man Low Density Array and real time quantitative polymerase chain reaction. To evaluate the power of the selected miRNAs to predict disease, we calculated the area under the receiver-operating-characteristic curves. The overall survival of HBV cirrhosis patients was analyzed via KaplanMeier analysis.RESULTS The levels of miR-375, miR-122 and miR-143 were significantly lower in HBV cirrhosis tissues, while miR-224 was significantly higher than in the controls(P <0.0001). The area under the curves of the receiver-operating-characteristic curve for the 4-miRNA panel was 0.991(95%CI: 0.974-1). Patients with a lower expression level of miR-224 or higher expression levels of miR-375, miR-122 and miR-143 had longer overall survival.CONCLUSIONThe four miRNAs(miR-375, miR-122, miR-143 and miR-224) may be helpful for early diagnosis of HBV infection, HBV cirrhosis, and prediction of its overall survival.
引用
收藏
页码:383 / 393
页数:11
相关论文
共 50 条
  • [31] Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma
    Kubo, Shoji
    Takemura, Shigekazu
    Tanaka, Shogo
    Shinkawa, Hiroji
    Nishioka, Takayoshi
    Nozawa, Akinori
    Kinoshita, Masahiko
    Hamano, Genya
    Ito, Tokuji
    Urata, Yorihisa
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (27) : 8249 - 8255
  • [32] Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma
    Kubo, S
    Nishiguchi, S
    Hirohashi, K
    Tanaka, H
    Tsukamoto, T
    Hamba, H
    Shuto, T
    Yamamoto, T
    Ikebe, T
    Kinoshita, H
    CANCER, 1999, 86 (05) : 793 - 798
  • [33] Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study
    Tsai, JF
    Jeng, JE
    Ho, MS
    Chang, WY
    Hsieh, MY
    Lin, ZY
    Tsai, JH
    BRITISH JOURNAL OF CANCER, 1997, 76 (07) : 968 - 974
  • [34] Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus
    Hung, Chao-Hung
    Hu, Tsung-Hui
    Lu, Sheng-Nan
    Kuo, Fang-Ying
    Chen, Chien-Hung
    Wang, Jing-Houng
    Huang, Chao-Min
    Lee, Chuan-Mo
    Lin, Chih-Yun
    Yen, Yi-Hao
    Chiu, Yi-Chun
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (03) : 714 - 720
  • [35] Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma
    Shoji Kubo
    Shigekazu Takemura
    Shogo Tanaka
    Hiroji Shinkawa
    Takayoshi Nishioka
    Akinori Nozawa
    Masahiko Kinoshita
    Genya Hamano
    Tokuji Ito
    Yorihisa Urata
    World Journal of Gastroenterology, 2015, (27) : 8249 - 8255
  • [36] mTOR Signaling: Roles in Hepatitis B Virus Infection and Hepatocellular Carcinoma
    Mei, Ling
    Sun, Huizhen
    Yan, Ying
    Ji, Huimin
    Su, Qian
    Chang, Le
    Wang, Lunan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (11): : 4178 - 4189
  • [37] Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review
    Huang, X.
    Hollinger, F. B.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (03) : 153 - 162
  • [38] Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
    Ito, Kenichi
    Arai, Makoto
    Imazeki, Fumio
    Yonemitsu, Yutaka
    Bekku, Dan
    Kanda, Tatsuo
    Fujiwara, Keiichi
    Fukai, Kenichi
    Sato, Kenichi
    Itoga, Sakae
    Nomura, Fumio
    Yokosuka, Osamu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (02) : 243 - 249
  • [39] Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy
    An, Mengchao
    Wang, Wenkang
    Zhang, Jie
    Till, Brian G.
    Zhao, Lingdi
    Huang, Hao
    Yang, Yonghao
    Li, Tiepeng
    Han, Lu
    Zhang, Xiaojie
    Qin, Peng
    Wang, Yunjian
    Zhang, Min
    Cui, Hong
    Gao, Quanli
    Wang, Zibing
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (02) : 385 - 395
  • [40] Update on the risk of hepatocellular carcinoma in chronic hepatitis B virus infection
    Hsu A.
    Lai C.-L.
    Yuen M.-F.
    Current Hepatitis Reports, 2011, 10 (2) : 106 - 111